新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识(建议)

2021-01-30 中华医学会精神病学分会 中国药物滥用防治杂志.2021.27(1):1-5.

新型冠状病毒肺炎(简称新冠肺炎)的暴发,给物质使用障碍患者的康复和诊治均带来了困难,也增加了普通大众滥用成瘾物质与发生成瘾行为如游戏障碍的风险。因此,疫情期间确保已有的成瘾患者继续接受规律、有效的治疗

中文标题:

新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识(建议)

发布日期:

2021-01-30

简要介绍:

新型冠状病毒肺炎(简称新冠肺炎)的暴发,给物质使用障碍患者的康复和诊治均带来了困难,也增加了普通大众滥用成瘾物质与发生成瘾行为如游戏障碍的风险。因此,疫情期间确保已有的成瘾患者继续接受规律、有效的治疗,降低复吸(发)风险以及预防新发患者的出现,成为当前亟待解决的问题。中国药物滥用防治协会、中华医学会精神医学分会药物依赖学组、中华医学会心身医学分会成瘾学组以及中国医师协会精神科医师分会成瘾医学专委会组织专家撰写了《新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识(建议)》,供公众预防成瘾相关问题及成瘾专业人员诊疗与管理工作借鉴。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4cfea1c0020ea1e2, title=新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识(建议), enTitle=, guiderFrom=中国药物滥用防治杂志.2021.27(1):1-5., authorId=0, author=, summary=新型冠状病毒肺炎(简称新冠肺炎)的暴发,给物质使用障碍患者的康复和诊治均带来了困难,也增加了普通大众滥用成瘾物质与发生成瘾行为如游戏障碍的风险。因此,疫情期间确保已有的成瘾患者继续接受规律、有效的治疗, cover=https://img.medsci.cn/2021327/1616860207082_2020535.jpg, journalId=0, articlesId=null, associationId=178, associationName=中华医学会精神病学分会, associationIntro=中华医学会精神病学分会是中华医学会下属的专科分会,是我国精神科医生最重要和影响最大的学术性行业学会。前身中华医学会神经精神科学会于1951年8月1日在北京成立,许英魁任主任委员,魏毓麟任副主任委员兼秘书。, copyright=0, guiderPublishedTime=Sat Jan 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>新型冠状病毒肺炎(简称新冠肺炎)的暴发,给物质使用障碍患者的康复和诊治均带来了困难,也增加了普通大众滥用成瘾物质与发生成瘾行为如游戏障碍的风险。因此,疫情期间确保已有的成瘾患者继续接受规律、有效的治疗,降低复吸(发)风险以及预防新发患者的出现,成为当前亟待解决的问题。中国药物滥用防治协会、中华医学会精神医学分会药物依赖学组、中华医学会心身医学分会成瘾学组以及中国医师协会精神科医师分会成瘾医学专委会组织专家撰写了《新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识(建议)》,供公众预防成瘾相关问题及成瘾专业人员诊疗与管理工作借鉴。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=111007, tagName=成瘾行为)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9604, guiderKeyword=药物成瘾, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9093, appHits=51, showAppHits=0, pcHits=495, showPcHits=9042, likes=0, shares=5, comments=7, approvalStatus=1, publishedTime=Sun Mar 28 00:59:20 CST 2021, publishedTimeString=2021-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 27 23:50:14 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 13:26:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识.pdf)])
新冠肺炎疫情期间物质使用与成瘾行为相关障碍防治专家共识.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1012586, encodeId=3bec10125865a, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Sun Aug 29 16:36:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959832, encodeId=667a9598321f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:10:35 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957648, encodeId=456e95e64831, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 16 18:09:38 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957352, encodeId=5c4195e3526f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 15 18:08:20 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956665, encodeId=a43e95666586, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 13 18:59:13 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-08-29 ms1000000448217959

    写得好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1012586, encodeId=3bec10125865a, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Sun Aug 29 16:36:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959832, encodeId=667a9598321f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:10:35 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957648, encodeId=456e95e64831, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 16 18:09:38 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957352, encodeId=5c4195e3526f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 15 18:08:20 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956665, encodeId=a43e95666586, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 13 18:59:13 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-04-23 jyzxjiangqin

    好共识!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1012586, encodeId=3bec10125865a, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Sun Aug 29 16:36:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959832, encodeId=667a9598321f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:10:35 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957648, encodeId=456e95e64831, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 16 18:09:38 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957352, encodeId=5c4195e3526f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 15 18:08:20 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956665, encodeId=a43e95666586, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 13 18:59:13 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-04-16 jyzxjiangqin

    好共识!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1012586, encodeId=3bec10125865a, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Sun Aug 29 16:36:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959832, encodeId=667a9598321f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:10:35 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957648, encodeId=456e95e64831, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 16 18:09:38 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957352, encodeId=5c4195e3526f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 15 18:08:20 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956665, encodeId=a43e95666586, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 13 18:59:13 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-04-15 jyzxjiangqin

    好共识!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1012586, encodeId=3bec10125865a, content=写得好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/1b78d61bf1164c5fb7d2adc95ea3502f/c3fd00bf5162442c86c07627abc5587d.jpg, createdBy=a0555557408, createdName=ms1000000448217959, createdTime=Sun Aug 29 16:36:20 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959832, encodeId=667a9598321f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 23 18:10:35 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957648, encodeId=456e95e64831, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Apr 16 18:09:38 CST 2021, time=2021-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957352, encodeId=5c4195e3526f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 15 18:08:20 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956665, encodeId=a43e95666586, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 13 18:59:13 CST 2021, time=2021-04-13, status=1, ipAttribution=)]
    2021-04-13 jyzxjiangqin

    好共识!

    0